Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Düzgün

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical and Experimental Rheumatology|November 2, 2004
Serum soluble CD30 levels in Behçet's diseaseN Düzgün, E Ayaslioglu, H Tutkak
Rheumatology International|April 30, 1999
Systemic amyloidosis and sacroiliitis in a patient with systemic lupus erythematosusN Düzgün, G Tokgöz, U Olmez, et al.
Rheumatology International|January 1, 1997
Seizures and hepatotoxicity following sulphasalazine administrationT Sentürk, A O Aydintuğ, N Düzgün, et al.
Tissue Antigens|September 10, 2009
Cytotoxic T lymphocyte-associated antigen-4 polymorphism in patients with rheumatic heart diseaseN Düzgün, T Duman, F E Haydardedeoğlu, et al.
Rheumatology International|January 1, 1997
The frequency of autoantibodies in Turkish patients with lupus nephritisN Düzgün, M Hoier-Madsen, A Wiik, et al.
Tissue Antigens|October 10, 2006
Genetic susceptibility to rheumatic heart disease and streptococcal pharyngitis: association with HLA-DR allelesF E Haydardedeoğlu, H Tutkak, K Köse, et al.
Rheumatology International|January 1, 1996
Fibronectin and circulating immune complexes in Behet's diseaseK Ozoran, N Düzgün, H Tutkak, et al.
Scandinavian Journal of Rheumatology|February 10, 2006
Characteristics of vascular involvement in Behçet's diseaseN Düzgün, A Ateş, O T Aydintuğ, et al.
Rheumatology International|January 1, 1997
Lupus vulgaris in a patient with systemic lupus erythematosus and persistent IgG deficiencyN Düzgün, M Duman, B Sonel, et al.
Rheumatology International|January 1, 1995
Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's diseaseA O Aydintuğ, G Tokgöz, K Ozoran, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical and Experimental Rheumatology|November 2, 2004
Serum soluble CD30 levels in Behçet's diseaseN Düzgün, E Ayaslioglu, H Tutkak
Rheumatology International|April 30, 1999
Systemic amyloidosis and sacroiliitis in a patient with systemic lupus erythematosusN Düzgün, G Tokgöz, U Olmez, et al.
Rheumatology International|January 1, 1997
Seizures and hepatotoxicity following sulphasalazine administrationT Sentürk, A O Aydintuğ, N Düzgün, et al.
Tissue Antigens|September 10, 2009
Cytotoxic T lymphocyte-associated antigen-4 polymorphism in patients with rheumatic heart diseaseN Düzgün, T Duman, F E Haydardedeoğlu, et al.
Rheumatology International|January 1, 1997
The frequency of autoantibodies in Turkish patients with lupus nephritisN Düzgün, M Hoier-Madsen, A Wiik, et al.
Tissue Antigens|October 10, 2006
Genetic susceptibility to rheumatic heart disease and streptococcal pharyngitis: association with HLA-DR allelesF E Haydardedeoğlu, H Tutkak, K Köse, et al.
Rheumatology International|January 1, 1996
Fibronectin and circulating immune complexes in Behet's diseaseK Ozoran, N Düzgün, H Tutkak, et al.
Scandinavian Journal of Rheumatology|February 10, 2006
Characteristics of vascular involvement in Behçet's diseaseN Düzgün, A Ateş, O T Aydintuğ, et al.
Rheumatology International|January 1, 1997
Lupus vulgaris in a patient with systemic lupus erythematosus and persistent IgG deficiencyN Düzgün, M Duman, B Sonel, et al.
Rheumatology International|January 1, 1995
Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's diseaseA O Aydintuğ, G Tokgöz, K Ozoran, et al.
Pageof 2